Drug induced osteonecrosis of the jaws.
Weeda
Lawrence W
LW
Department of Oral and Maxillofacial Surgery, University of Tennessee, College of Dentistry, Memphis, USA.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010010:Osteoclasts / Q000187:drug effects; D010019:Osteomyelitis / Q000139:chemically induced; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control; D000077268:Pamidronate; D013165:Splints; D000077211:Zoledronic Acid
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate